X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - DRUGS.COM - Pharma Industry News - 14/Oct 15:10

FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

TUESDAY, Oct. 14, 2025 -- The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets to treat idiopathic pulmonary fibrosis (IPF). This is the first new therapy in more than 10 years to be approved for IPF, according to a...

Articles similaires

Sorry! Image not available at this time

CHEST: Nerandomilast Slows Decline in FVC in Idiopathic Pulmonary Fibrosis

drugs.com - 23/Oct 16:10

THURSDAY, Oct. 23, 2025 -- For U.S. patients with idiopathic pulmonary fibrosis (IPF), nerandomilast slows the decline in forced vital capacity (FVC),...

Sorry! Image not available at this time

FDA Approves Lynkuet (elinzanetant) for Moderate to Severe Hot Flashes Due to Menopause

drugs.com - 24/Oct 20:10

WHIPPANY, N.J., October 24, 2025 – Bayer announced today the U.S. Food and Drug Administration (FDA) has approved Lynkuet® (elinzanetant)...

Sorry! Image not available at this time

FDA Approves Lynkuet (elinzanetant) for Moderate to Severe Hot Flashes Due to Menopause

drugs.com - 24/Oct 20:10

WHIPPANY, N.J., October 24, 2025 – Bayer announced today the U.S. Food and Drug Administration (FDA) has approved Lynkuet® (elinzanetant)...

Sorry! Image not available at this time

FDA Approves Expanded Pediatric Indications for Yuflyma (adalimumab-aaty)

drugs.com - 17/Oct 21:10

INCHEON, South Korea, Oct. 17, 2025 -- Celltrion, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved expanded...

Sorry! Image not available at this time

FDA Approves Tezspire for Chronic Rhinosinusitis With Nasal Polyps

drugs.com - 14:10

TUESDAY, Oct. 28, 2025 -- The U.S. Food and Drug Administration approved Tezspire (tezepelumab-ekko; Amgen) for the add-on maintenance treatment of...

Sorry! Image not available at this time

New Nonhormonal Drug, Lynkuet, Approved to Treat Menopause Symptoms

drugs.com - 27/Oct 15:10

MONDAY, Oct. 27, 2025 — The U.S. Food and Drug Administration (FDA) has approved a new nonhormonal treatment to help women manage menopause...

Sorry! Image not available at this time

New Nonhormonal Drug, Lynkuet, Approved to Treat Menopause Symptoms

drugs.com - 27/Oct 15:10

MONDAY, Oct. 27, 2025 — The U.S. Food and Drug Administration (FDA) has approved a new nonhormonal treatment to help women manage menopause...

Sorry! Image not available at this time

FDA Approves Tezspire (tezepelumab-ekko) for Chronic Rhinosinusitis with Nasal Polyps

drugs.com - 17/Oct 22:10

THOUSAND OAKS, Calif., Oct. 17, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and AstraZeneca today announced that the U.S. Food and Drug Administration...

Sorry! Image not available at this time

FDA Approves Tezspire (tezepelumab-ekko) for Chronic Rhinosinusitis with Nasal Polyps

drugs.com - 17/Oct 22:10

THOUSAND OAKS, Calif., Oct. 17, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and AstraZeneca today announced that the U.S. Food and Drug Administration...

Sorry! Image not available at this time

PureTech Presents New Phase 2b Analyses Demonstrating Consistent Safety and Efficacy of Deupirfenidone in Older Patients with Idiopathic Pulmonary Fibrosis (IPF), a Historically Undertreated Group

wn.com - 22/Oct 08:47

Data presented at the CHEST 2025 Annual Meeting highlight deupirfenidone’s differentiated profile and potential to address unmet needs across age...

Les derniers communiqués